A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates

We recently reported the clinical results of a Phase I trial combining ipilimumab with a vaccine containing transgenes for prostate-specific antigen (PSA) and for a triad of costimulatory molecules (PROSTVAC) in patients with metastatic castration-resistant prostate cancer. Thirty patients were trea...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancer Immunol Immunother
Главные авторы: Jochems, Caroline, Tucker, Jo A., Tsang, Kwong-Yok, Madan, Ravi A., Dahut, William L., Liewehr, David J., Steinberg, Seth M., Gulley, James L., Schlom, Jeffrey
Формат: Artigo
Язык:Inglês
Опубликовано: Springer Berlin Heidelberg 2014
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6314199/
https://ncbi.nlm.nih.gov/pubmed/24514956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-014-1524-0
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы